Developing Personalized Medicine Strategies to Increase Physical Activity in Parkinson's Disease (PD) Through Digital Health Technology
1 other identifier
observational
88
1 country
1
Brief Summary
Under a grant from the Department of Defense's PD program, Dr. Morley's is investigating new approaches that 1) use "gamification"- applying rules of games like point scoring, achieving silver, gold or platinum levels and competition-- to increase physical activity in PD; 2) identify whether certain PD patient respond differently to gamification interventions than others.; 3) use readily and commercially available (including Fitbits) digital health technologies to perform all study activities remotely and enable a "touchless" study where patients don't have to come in person for any studies visits. The study is underway and actively recruiting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 3, 2021
CompletedFirst Submitted
Initial submission to the registry
September 1, 2022
CompletedFirst Posted
Study publicly available on registry
September 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedJuly 29, 2024
July 1, 2024
2.6 years
September 1, 2022
July 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Determine the feasibility and acceptability of a "touchless" intervention to increase physical activity in patients with PD using digital health technology and behavioral economics strategies
Protocols using gamification to increase physical activity in patients with PD employing remote intervention and assessment will be feasible and acceptable to participants. Specifically we hypothesize that subjects will: H1a) wear their activity monitor ≥ 80% of the time; H1b) successfully create a remote monitoring account and sync their device; H1c) wear and capture motor symptoms with the PKG and H1d) report high program acceptability (Intrinsic Motivation Inventory score ≥ 5)
2026
Determine whether non-motor features predict responsiveness to a behavioral economic-based gamification intervention to increase physical activity in patients with PD
Non-motor and features, in particular risk aversion as measured by the DOSPERT scale, will be associated with change in daily step count during the gamification intervention
2026
Determine whether changes in physical activity in response to a gamification intervention impact PD motor symptoms measured using a remotely-monitored wearable device
Increased activity during the gamification intervention will be associated with improvement of motor scores remotely measured using the Parkinson's Kineticgraph (PKG)
2026
Eligibility Criteria
Veteran participants within the VISN4 region (a network of 9 VA medical centers and 45 outpatient clinics, covering Pennsylvania, Delaware and parts of Ohio, West Virginia, New York and New Jersey).
You may qualify if:
- Have a clinical diagnosis of PD.
- Are on a stable regimen of anti-parkinsonian medication that have not changed since the prior visit.
- Have not fallen more than once within the past year.
- To the greatest extent possible, seek to include and study Veterans with deployment, environmental, or occupational exposures as risk factors for Parkinson's disease. These will include neurotoxins (Agent Orange, Camp Lejune groundwater, Southwest Asia burn pits) and Traumatic Brain Injury, as these exposures are commonly encountered in our Veteran population and are of significant interest as risk factors for PD.
You may not qualify if:
- Diagnosis of an atypical parkinsonian syndrome or concomitant administration of a drug that could cause parkinsonian syndromes.
- Cardiovascular or other medical comorbidities that preclude participation in an intervention to increase physical activity
- Lack of access to a smartphone or other device (tablet or networked computer) that can be used to interface with the Fitbit app and Way to Health platform
- PD Hoehn/Yahr stage \>2.5 indicating significant balance or functional impairment that would preclude participation in an intervention to increase physical activity
- Clinical diagnosis of dementia
- Active impulse control disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James Morley
Corporal Michael J. Crescenz VA Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-director, Parkinson's Disease Research, Education and Clinical Center, Crescenz VAMC
Study Record Dates
First Submitted
September 1, 2022
First Posted
September 6, 2022
Study Start
December 3, 2021
Primary Completion
July 1, 2024
Study Completion
July 1, 2024
Last Updated
July 29, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share